Portefeuille d'ETF LABU (NYSE) - Page 5 | MetaTrader

Afficher le graphique complet

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

TNGX Tango Therapeutics Inc. 2.4 M 113.0 K 0.5%

CLDX Celldex Therapeutics Inc. 2.3 M 70.0 K 0.4%

CAPR CAPRICOR THERAPEUTICS INC 2.3 M 67.1 K 0.4%

VCEL Vericel Corporation 2.2 M 63.9 K 0.4%

INBX Inhibrx Biosciences Inc. 2.2 M 17.0 K 0.4%

GLUE Monte Rosa Therapeutics Inc 2.2 M 112.6 K 0.4%

NVAX Novavax Inc 2.1 M 267.4 K 0.4%

BHVN Biohaven Ltd 2.1 M 220.2 K 0.4%

STOK Stoke Therapeutics Inc 2.1 M 64.5 K 0.4%

RLAY Relay Therapeutics Inc 2.1 M 162.1 K 0.4%

TSHA Taysha Gene Therapies Inc. 2.1 M 322.8 K 0.4%

VRDN Viridian Therapeutics Inc 2.1 M 152.8 K 0.4%

OLMA Olema Pharmaceuticals Inc. 2.0 M 141.6 K 0.4%

PVLA Palvella Therapeutics Inc. 2.0 M 15.7 K 0.4%

QURE Uniqure N.V. 1.9 M 97.2 K 0.4%

ANAB AnaptysBio Inc. 1.9 M 29.3 K 0.4%

CRVS Corvus Pharmaceuticals Inc 1.8 M 121.2 K 0.4%

MNKD MANNKIND CORP 1.8 M 625.9 K 0.3%

CDNA Caredx Inc 1.8 M 84.7 K 0.3%

K

KALV KALVISTA PHARMACEUTICALS INC 1.6 M 61.7 K 0.3%

1
2
3
4
5
6
7
8